Paper41449752
The importance of assessing the fitness of older patients with newly diagnosed diffuse large B-cell lymphoma and classic Hodgkin lymphoma.
Zilioli VR and 5 others. Br J Haematol, 2026. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. The importance of assessing the fitness of older patients with newly diagnosed diffuse large B-cell lymphoma and classic Hodgkin lymphoma. Papers, record 41449752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41449752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The importance of assessing the fitness of older patients with newly diagnosed diffuse large B-cell lymphoma and classic Hodgkin lymphoma.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | Major topic |
| Hodgkin Disease | Major topic |
| Geriatric Assessment | Major topic |
| Humans | |
| Aged | |
| Prognosis | |
| Aged, 80 and over | |
| Frailty | |
| Female | |
| Male |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22117038 | A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era. | Blood | 2012 | https://conductscience.org/library/papers/22117038 | PubMed |
| 2 | 34041751 | Association of the Geriatric 8 with treatment intensity and prognosis in older patients with diffuse large B-cell lymphoma. | Br J Haematol | 2021 | https://conductscience.org/library/papers/34041751 | PubMed |
| 3 | 20392703 | Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. | Age Ageing | 2010 | https://conductscience.org/library/papers/20392703 | PubMed |
| 4 | 34448831 | Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma. | Blood Adv | 2021 | https://conductscience.org/library/papers/34448831 | PubMed |
| 5 | 34162178 | Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study. | Haematologica | 2022 | https://conductscience.org/library/papers/34162178 | PubMed |
| 6 | 19562776 | A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. | Cancer | 2009 | https://conductscience.org/library/papers/19562776 | PubMed |
| 7 | 39316716 | The current landscape of frontline large B-cell lymphoma trials. | Blood | 2025 | https://conductscience.org/library/papers/39316716 | PubMed |
| 8 | 23509323 | How can outcomes be improved for older patients with Hodgkin lymphoma? | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23509323 | PubMed |
| 9 | 12406082 | Hodgkin's disease in the elderly: a population-based study. | Br J Haematol | 2002 | https://conductscience.org/library/papers/12406082 | PubMed |
| 10 | 25110825 | Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL). | Leuk Lymphoma | 2015 | https://conductscience.org/library/papers/25110825 | PubMed |
| 11 | 33577377 | Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi. | J Clin Oncol | 2021 | https://conductscience.org/library/papers/33577377 | PubMed |
| 12 | 31228094 | Considerations for the Treatment of Diffuse Large B Cell Lymphoma in the Elderly. | Curr Hematol Malig Rep | 2019 | https://conductscience.org/library/papers/31228094 | PubMed |
| 13 | 27104110 | Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. | J Cachexia Sarcopenia Muscle | 2016 | https://conductscience.org/library/papers/27104110 | PubMed |
| 14 | 36495588 | The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium. | J Clin Oncol | 2023 | https://conductscience.org/library/papers/36495588 | PubMed |
| 15 | 17488980 | Comprehensive geriatric assessment for older patients with cancer. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17488980 | PubMed |
| 16 | 36098030 | Frailty assessment in the care of older people with haematological malignancies. | Lancet Healthy Longev | 2021 | https://conductscience.org/library/papers/36098030 | PubMed |
| 17 | 40357855 | Comparative Effectiveness of R-miniCOMP Versus R-miniCHOP in Older Non-Fit Patients With Diffuse Large B-Cell Lymphoma: Insights From a "Fondazione Italiana Linfomi" Cohort Study. | Hematol Oncol | 2025 | https://conductscience.org/library/papers/40357855 | PubMed |
| 18 | 23781925 | Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy. | Leuk Lymphoma | 2014 | https://conductscience.org/library/papers/23781925 | PubMed |
| 19 | 28524259 | Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi. | Hematol Oncol | 2018 | https://conductscience.org/library/papers/28524259 | PubMed |
| 20 | 21482186 | Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. | Lancet Oncol | 2011 | https://conductscience.org/library/papers/21482186 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42694221 | Age and CIRS-G for risk stratification in elderly esophageal squamous cell carcinoma patients receiving definitive chemoradiotherapy. | Front Oncol | 2026 | https://conductscience.org/library/papers/42694221 | PubMed |
| 42460098 | Classical Hodgkin Lymphoma Today. | Mediterr J Hematol Infect Dis | 2026 | https://conductscience.org/library/papers/42460098 | PubMed |
| 41449752 | The importance of assessing the fitness of older patients with newly diagnosed diffuse large B-cell lymphoma and classic Hodgkin lymphoma. | Br J Haematol | 2026 | https://conductscience.org/library/papers/41449752 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41449752
GET https://conductscience.org/api/papers/v1/41449752/references?page=2